Piramal Healthcare is planning a string of acquisitions in the biotech space in the US, Europe and Canada in the next two to three years. The company intends to make up for the Rs 2,000-crore (Rs......
Drug firm Piramal Healthcare on Tuesday said it will acquire assets of troubled Canadian medical device firm BioSyntech for Canadian $3.9 million (around Rs 17 crore). Piramal, which in 2006 had......